🔎 Trials Near Me

Dachaigh › Cancer Hypopharyngeal › Kansas › Overland Park

Sgrùdaidhean clionaigeach Cancer Hypopharyngeal ann an Overland Park, KS

Tha 4 sgrùdaidhean airson Cancer Hypopharyngeal a’ lorg phàirtichean aig làraichean ann agus timcheall air Overland Park (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

A’ fastadhÌre 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06589804

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

A’ fastadhÌre 1
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05172245

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

A’ fastadhÌre 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07441681

Integrated Cancer Repository for Cancer Research

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Saint Luke's Cancer Instititute - South, Overland Park
Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

Sgrùdaidhean Cancer Hypopharyngeal ann am bailtean eile

Sgrùdaidhean eile ann an Overland Park

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.